Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8652992 | The Annals of Thoracic Surgery | 2017 | 8 Pages |
Abstract
No significant outcome differences in perioperative cardiovascular or hemorrhagic events were identified among the groups. Although these findings suggest that clopidogrel may be discontinued shortly before the operation with limited risk of bleeding, we also found that holding therapy for more than 14 days preoperatively may be safe in appropriately selected patients.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Scott M. MD, Arlene M. PhD, Wayne L. MD, Reza J. MD, David C. MD, Jack A. MD, Boris MD, Stephen G. MD, Ara A. MD, Garrett MD, Mara B. MD,